From: Anti-West Nile virus activity of in vitro expanded human primary natural killer cells
Days Post Treatment | 1 | 2 | 3 | 4 | 5 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|
Normal control | - | - | - | - | - | - | - | - | - |
WNV control | - | - | + | + | 3+ | 4+ | 4+ | 4+ | 4+ |
NK cells 10 million | - | - | - | - | - | - | - | - | - |
NK cells 1 million | - | - | - | - | + | 4+ | 4+ | 4+ | 4+ |
NK cells 0.1 million | - | - | - | + | 2+ | 4+ | 4+ | 4+ | 4+ |
NK sup 1:2 | - | - | - | - | - | - | - | - | - |
NK sup 1:10 | - | - | - | - | + | 4+ | 4+ | 4+ | 4+ |
NK sup 1:100 | - | - | - | + | 2+ | 4+ | 4+ | 4+ | 4+ |
NK sup1:1000 | - | - | - | + | 3+ | 4+ | 4+ | 4+ | 4+ |